Which has higher valuation and earnings, RCEL or NPCE?

NeuroPace has higher revenue and earnings than Avita Medical. NeuroPace is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $72.35M 1.87 -$48.59M -$1.57 N/A NeuroPace $99.53M 4.42 -$21.47M -$0.65 N/A

Is RCEL or NPCE more profitable?

NeuroPace has a net margin of -21.67% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat NeuroPace's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% NeuroPace -21.67% -108.20% -18.50%

Does the media favor RCEL or NPCE?

In the previous week, NeuroPace had 5 more articles in the media than Avita Medical. MarketBeat recorded 10 mentions for NeuroPace and 5 mentions for Avita Medical. NeuroPace's average media sentiment score of 0.76 beat Avita Medical's score of 0.33 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroPace 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer KIDS or RCEL?

In the previous week, Avita Medical had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for Avita Medical and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.89 beat Avita Medical's score of 0.33 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor RCEL or SI?

In the previous week, Avita Medical and Avita Medical both had 5 articles in the media. Shoulder Innovations' average media sentiment score of 0.41 beat Avita Medical's score of 0.33 indicating that Shoulder Innovations is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RCEL or CLPT?

In the previous week, Avita Medical and Avita Medical both had 5 articles in the media. ClearPoint Neuro's average media sentiment score of 1.06 beat Avita Medical's score of 0.33 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RCEL or DCTH?

In the previous week, Avita Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Avita Medical and 4 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.61 beat Avita Medical's score of 0.33 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Delcath Systems 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avita Medical (RCEL) Competitors

$4.40 -0.09 (-2.00%)

Closing price 04:00 PM Eastern

Extended Trading

$4.42 +0.02 (+0.57%)

As of 07:34 PM Eastern

Compare

RCEL vs. NPCE, KIDS, SI, CLPT, and DCTH

Should you buy Avita Medical stock or one of its competitors? MarketBeat compares Avita Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avita Medical include NeuroPace (NPCE), OrthoPediatrics (KIDS), Shoulder Innovations (SI), ClearPoint Neuro (CLPT), and Delcath Systems (DCTH).

How does Avita Medical compare to NeuroPace?

Avita Medical (NASDAQ:RCEL) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

NeuroPace has a net margin of -21.67% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
NeuroPace	-21.67%	-108.20%	-18.50%

Avita Medical currently has a consensus target price of $7.25, indicating a potential upside of 64.77%. NeuroPace has a consensus target price of $19.29, indicating a potential upside of 49.62%. Given Avita Medical's higher possible upside, equities research analysts clearly believe Avita Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
NeuroPace	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.80

In the previous week, NeuroPace had 5 more articles in the media than Avita Medical. MarketBeat recorded 10 mentions for NeuroPace and 5 mentions for Avita Medical. NeuroPace's average media sentiment score of 0.76 beat Avita Medical's score of 0.33 indicating that NeuroPace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroPace	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, NeuroPace has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market.

NeuroPace has higher revenue and earnings than Avita Medical. NeuroPace is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A
NeuroPace	$99.53M	4.42	-$21.47M	-$0.65	N/A

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 19.2% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

NeuroPace beats Avita Medical on 14 of the 17 factors compared between the two stocks.

How does Avita Medical compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

OrthoPediatrics presently has a consensus target price of $24.78, indicating a potential upside of 22.72%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 64.77%. Given Avita Medical's higher possible upside, analysts plainly believe Avita Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

OrthoPediatrics has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market.

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Comparatively, 2.2% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

OrthoPediatrics has higher revenue and earnings than Avita Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.19	-$39.65M	-$1.68	N/A
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A

OrthoPediatrics has a net margin of -16.31% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Avita Medical	-62.67%	N/A	-78.92%

In the previous week, Avita Medical had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for Avita Medical and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.89 beat Avita Medical's score of 0.33 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OrthoPediatrics beats Avita Medical on 10 of the 16 factors compared between the two stocks.

How does Avita Medical compare to Shoulder Innovations?

Avita Medical (NASDAQ:RCEL) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Shoulder Innovations has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A
Shoulder Innovations	$47.32M	9.95	-$40.36M	-$166.96	N/A

In the previous week, Avita Medical and Avita Medical both had 5 articles in the media. Shoulder Innovations' average media sentiment score of 0.41 beat Avita Medical's score of 0.33 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical has a net margin of -62.67% compared to Shoulder Innovations' net margin of -81.78%. Avita Medical's return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Avita Medical currently has a consensus price target of $7.25, suggesting a potential upside of 64.77%. Shoulder Innovations has a consensus price target of $22.00, suggesting a potential downside of 3.07%. Given Avita Medical's higher possible upside, equities analysts plainly believe Avita Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

27.7% of Avita Medical shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Shoulder Innovations beats Avita Medical on 8 of the 14 factors compared between the two stocks.

How does Avita Medical compare to ClearPoint Neuro?

Avita Medical (NASDAQ:RCEL) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

ClearPoint Neuro has lower revenue, but higher earnings than Avita Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A
ClearPoint Neuro	$40.61M	11.03	-$25.54M	-$1.01	N/A

Avita Medical currently has a consensus target price of $7.25, indicating a potential upside of 64.77%. ClearPoint Neuro has a consensus target price of $23.00, indicating a potential upside of 53.95%. Given Avita Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Avita Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Avita Medical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

In the previous week, Avita Medical and Avita Medical both had 5 articles in the media. ClearPoint Neuro's average media sentiment score of 1.06 beat Avita Medical's score of 0.33 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
ClearPoint Neuro	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical has a net margin of -62.67% compared to ClearPoint Neuro's net margin of -71.57%. Avita Medical's return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Avita Medical beats ClearPoint Neuro on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Delcath Systems?

Avita Medical (NASDAQ:RCEL) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

Avita Medical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market.

Delcath Systems has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A
Delcath Systems	$90.44M	4.66	$2.70M	$0.01	1,222.00

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 2.2% of Avita Medical shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Avita Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Avita Medical and 4 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.61 beat Avita Medical's score of 0.33 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Delcath Systems	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems has a net margin of 0.62% compared to Avita Medical's net margin of -62.67%. Delcath Systems' return on equity of 0.51% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Delcath Systems	0.62%	0.51%	0.46%

Avita Medical currently has a consensus target price of $7.25, suggesting a potential upside of 64.77%. Delcath Systems has a consensus target price of $22.17, suggesting a potential upside of 81.40%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts plainly believe Delcath Systems is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Delcath Systems beats Avita Medical on 14 of the 16 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$135.42M	$5.56B	$6.83B	$12.41B
Dividend Yield	N/A	1.78%	2.59%	10.11%
P/E Ratio	-2.80	23.19	281.83	23.65
Price / Sales	1.87	60.54	585.86	92.89
Price / Cash	N/A	32.15	69.88	58.30
Price / Book	-8.00	6.31	10.93	5.84
Net Income	-$48.59M	$146.99M	$3.49B	$336.16M
7 Day Performance	-4.56%	1.84%	-0.30%	0.03%
1 Month Performance	6.54%	6.91%	-2.59%	-5.22%
1 Year Performance	-16.98%	1.12%	66.21%	17.37%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	3.2797 of 5 stars	$4.40 -2.0%	$7.25 +64.8%	-16.2%	$135.42M	$72.35M	N/A	130	Upcoming Earnings
NPCE NeuroPace	3.1456 of 5 stars	$15.47 +1.1%	$19.29 +24.6%	+57.0%	$526.17M	$99.53M	N/A	170	News Coverage Positive News Analyst Forecast
KIDS OrthoPediatrics	2.6511 of 5 stars	$19.99 +0.9%	$24.78 +23.9%	-7.2%	$511.42M	$236.35M	N/A	200	Upcoming Earnings
SI Shoulder Innovations	1.5675 of 5 stars	$22.24 +6.1%	$22.00 -1.1%	N/A	$459.08M	$47.32M	N/A	61	Analyst Forecast
CLPT ClearPoint Neuro	3.1642 of 5 stars	$14.33 -1.9%	$23.00 +60.5%	+36.8%	$425.14M	$40.61M	N/A	110	News Coverage Positive News Upcoming Earnings Analyst Revision Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. NPCE, KIDS, SI, CLPT, and DCTH

How does Avita Medical compare to NeuroPace?

Summary

How does Avita Medical compare to OrthoPediatrics?

Summary

How does Avita Medical compare to Shoulder Innovations?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Summary

How does Avita Medical compare to Delcath Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. NPCE, KIDS, SI, CLPT, and DCTH

How does Avita Medical compare to NeuroPace?

Is RCEL or NPCE more profitable?

Do analysts prefer RCEL or NPCE?

Does the media favor RCEL or NPCE?

Which has more risk & volatility, RCEL or NPCE?

Which has higher valuation and earnings, RCEL or NPCE?

Do institutionals and insiders believe in RCEL or NPCE?

Summary

How does Avita Medical compare to OrthoPediatrics?

Do analysts prefer KIDS or RCEL?

Which has more volatility and risk, KIDS or RCEL?

Do insiders & institutionals have more ownership in KIDS or RCEL?

Which has higher earnings and valuation, KIDS or RCEL?

Is KIDS or RCEL more profitable?

Does the media prefer KIDS or RCEL?

Summary

How does Avita Medical compare to Shoulder Innovations?

Which has preferable earnings and valuation, RCEL or SI?

Does the media favor RCEL or SI?

Is RCEL or SI more profitable?

Do analysts prefer RCEL or SI?

Do insiders & institutionals hold more shares of RCEL or SI?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Which has preferable valuation and earnings, RCEL or CLPT?

Do analysts recommend RCEL or CLPT?

Which has more volatility and risk, RCEL or CLPT?

Does the media refer more to RCEL or CLPT?

Is RCEL or CLPT more profitable?

Do institutionals & insiders believe in RCEL or CLPT?

Summary

How does Avita Medical compare to Delcath Systems?

Which has more volatility & risk, RCEL or DCTH?

Which has better valuation and earnings, RCEL or DCTH?

Do institutionals and insiders have more ownership in RCEL or DCTH?

Does the media refer more to RCEL or DCTH?

Is RCEL or DCTH more profitable?

Do analysts recommend RCEL or DCTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools